Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
GSK3008348 is an integrin αVβ6 inhibitor (Ki = 0.01 nM).1 It is selective for integrin αVβ6 over integrins αVβ1, αVβ3, αVβ5, and αVβ8 (IC50s = 3.9, 50, 1,000, 126, and 16 nM, respectively, in cell adhesion assays). GSK3008348 induces internalization and degradation of integrin αVβ6 and reduces the phosphorylation of SMAD2 in normal human bronchial epithelial (NHBE) cells.2 Intranasal administration of GSK3008348 (3 mg/kg) decreases lung collagen levels in a mouse model of lung fibrosis induced by bleomycin (Item No. 13877).
WARNING This product is not for human or veterinary use.
1. .
2. .